Nutriband Inc. (NASDAQ:NTRBW) Short Interest Update

Nutriband Inc. (NASDAQ:NTRBW) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 1,746 shares, a growth of 9,600.0% from the August 15th total of 18 shares. Based on an average trading volume of 10,970 shares, the days-to-cover ratio is presently 0.2 days.

Hedge Funds Weigh In On Nutriband

An institutional investor recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new stake in Nutriband Inc. (NASDAQ:NTRBW) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband makes up approximately 0.1% of Empery Asset Management LP’s holdings, making the stock its 20th largest position.

Nutriband Stock Up 95.0%

NASDAQ NTRBW traded up $0.19 during trading on Thursday, reaching $0.39. 7,206 shares of the stock traded hands, compared to its average volume of 3,863. Nutriband has a fifty-two week low of $0.17 and a fifty-two week high of $2.99. The stock’s 50-day moving average price is $0.55 and its 200 day moving average price is $0.98.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.